Regeneron · 1 day ago
Sr Assoc Scientist, Therapeutic Antibodies (Pharmacokinetics)
Regeneron is seeking a motivated Sr. Associate Scientist to join their Research Pharmacokinetics and Sample Analyses Team within the Therapeutic Proteins organization. The role involves providing assistance in PK study and sample analysis, conducting in vivo testing, and performing data analysis to report experimental results.
BiopharmaBiotechnologyPharmaceutical
Responsibilities
Provide PK study and sample analysis assistance for timeline driven experiments
Conduct in vivo testing and ex vivo sample analysis using immunoassay methods, including assay development/optimization if required
Perform data analysis and report experimental results in both verbal and written communications
Work effectively either as a team player or as an independent individual
Qualification
Required
B.S. or M.S. degrees in biology or a related field
3+ (MS) - 6+ (BS) years of laboratory experience
Experience with microtiter plate-based assays, such as ELISA
Basic rodent handling techniques
Good communication skills
Excellent organization skills with the ability to pay attention to details
General computer skills such as Excel and PowerPoint
Preferred
Experience with analysis using a GyroLab xPlore analysis system
Experience with GraphPad Prism
Benefits
Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)
Company
Regeneron
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.
H1B Sponsorship
Regeneron has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)
Funding
Current Stage
Public CompanyTotal Funding
$15.93MKey Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M
Leadership Team
Recent News
2026-01-09
2026-01-08
Company data provided by crunchbase